Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | President AS and AET | June 14, 2024 | June 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date June 14, 2024 · Filed June 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63 |
Ending reported balance
After 2024-06-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-06-14 · Exercise / conversion · Acquired 4,000 · Balance 4,063 Row 2 · 2024-06-14 · Sale · Disposed 4,000 · Balance 63 |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.93 · Expires 2027-03-01 | Direct | 0 |
Reported balance
After 2024-06-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-14 · Exercise / conversion · Disposed 4,000 · Balance 0 F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2024 Filed Jun 17, 2024 20:22 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-24-018832 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:22 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,000 | $71.82 | $287,280.00 |
DisclosureSEC source: 0001127602-24-018832 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:22 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,000 | $41.93 | $167,720.00 |
DisclosureSEC source: 0001127602-24-018832 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 33,508 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008535 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,508 Underlying: Common Stock · 33,508 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2023 Filed Feb 7, 2024 02:40 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 111.163 | $109.51 | $12,173.46 |
DisclosureSEC source: 0001127602-24-003607 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,424.357 F1 · date: As of 12/31/23. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,300 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-028980 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,300 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,300 | $109.93 | $252,833.48 |
DisclosureSEC source: 0001127602-23-028980 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.91 to $109.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 17:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,300 | $41.93 | $96,439.00 |
DisclosureSEC source: 0001127602-23-028980 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 18:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,200 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-027084 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 1,200 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 18:42 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,200 | $102.40 | $122,874.00 |
DisclosureSEC source: 0001127602-23-027084 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 18:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,200 | $41.93 | $50,316.00 |
DisclosureSEC source: 0001127602-23-027084 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:38 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-024253 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:38 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,000 | $107.31 | $214,629.20 |
DisclosureSEC source: 0001127602-23-024253 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:38 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,000 | $41.93 | $83,860.00 |
DisclosureSEC source: 0001127602-23-024253 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-018442 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 5,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:40 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,000 | $131.14 | $655,676.00 |
DisclosureSEC source: 0001127602-23-018442 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.07 to $131.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,000 | $41.93 | $209,650.00 |
DisclosureSEC source: 0001127602-23-018442 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-016612 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 1,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:55 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,500 | $120.90 | $181,342.50 |
DisclosureSEC source: 0001127602-23-016612 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,500 | $41.93 | $62,895.00 |
DisclosureSEC source: 0001127602-23-016612 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-016278 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 1,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:06 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,500 | $119.24 | $178,861.05 |
DisclosureSEC source: 0001127602-23-016278 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,500 | $41.93 | $62,895.00 |
DisclosureSEC source: 0001127602-23-016278 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:21 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 20,843 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008927 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,843 Underlying: Common Stock · 20,843 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2022 Filed Feb 6, 2023 21:16 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 112.168 | $88.64 | $9,942.57 |
DisclosureSEC source: 0001127602-23-003558 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,313.194 F1 · date: As of December 31, 2022. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 01:01 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-020992 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 7,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 01:01 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 7,500 | $100.90 | $756,750.00 |
DisclosureSEC source: 0001127602-22-020992 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 01:01 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 7,500 | $41.93 | $314,475.00 |
DisclosureSEC source: 0001127602-22-020992 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:03 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 35,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008095 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · derivative · entry 7 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 8,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,700 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,700 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,582 | $149.36 | $236,281.19 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 6,418 | $148.36 | $952,155.23 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,645 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.93. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 8,000 | $41.93 | $335,440.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,700 | $148.00 | $399,600.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 Read SEC document |
| February 25, 2022 Filed Feb 28, 2022 22:05 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,700 | $39.87 | $107,649.00 |
DisclosureSEC source: 0001127602-22-007085 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 22:06 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 116.404 | $141.76 | $16,501.43 |
DisclosureSEC source: 0001127602-22-003990 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,201.026 F1 · date: As of December 31, 2021. F2 · balance_after: No change in holdings other than as a result of a change of stock in the 401(K) CONMED fund. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 16:41 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-028434 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Common Stock · 14,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 16:41 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 14,000 | $154.06 | $2,156,854.00 |
DisclosureSEC source: 0001127602-21-028434 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 16:41 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 14,000 | $39.87 | $558,180.00 |
DisclosureSEC source: 0001127602-21-028434 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:34 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 26,350 | $0.00 Strike: $122.55 | $0.00 |
DisclosureSEC source: 0001127602-21-009295 · form4.xml · derivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,350 Underlying: Common Stock · 26,350 shares Expires 2031-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2020 Filed Feb 5, 2021 21:23 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 151.337 | $112.00 | $16,949.74 |
DisclosureSEC source: 0001127602-21-004173 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,084.622 F1 · date: As of December 31, 2020. F2 · balance_after: No change in holdings other than as a result of a change in the shares of stock in the 401(K) Conmed fund. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 20:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 6,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-031505 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,700 Underlying: Common Stock · 6,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 20:00 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 6,000 | $108.70 | $652,200.00 |
DisclosureSEC source: 0001127602-20-031505 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.66 to $108.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 20:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 6,000 | $39.87 | $239,220.00 |
DisclosureSEC source: 0001127602-20-031505 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 9,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,700 Underlying: Common Stock · 9,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 446 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · derivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,700 Underlying: Common Stock · 446 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 9,000 | $94.30 | $848,733.30 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.25 to $94.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 9,000 | $39.87 | $358,830.00 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 446 | $94.52 | $42,156.10 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.48 to $94.537. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.